SuperPATH® Minimally Invasive Total Hip Arthroplasty - An Australian Experience

Normal.dotm 0 0 1 187 1067 8 2 1310 12.0 0 false 18 pt 18 pt 0 0 false false false /* Style Definitions */ table.MsoNormalTable {mso-style-name:"Table Normal"; mso-tstyle-rowband-size:0; mso-tstyle-colband-size:0; mso-style-noshow:yes; mso-style-parent:""; mso-padding-alt:0in 5.4pt 0in 5.4pt; mso-para-margin:0in; mso-para-margin-bottom:.0001pt; mso-pagination:widow-orphan; font-size:12.0pt; font-family:"Times New Roman"; mso-ascii-font-family:Cambria; mso-ascii-theme-font:minor-latin; mso-hansi-font-family:Cambria; mso-hansi-theme-font:minor-latin;} Introduction: SuperPATH is a new minimally invasive technique for hip replacement surgery that was introduced in Australia in 2013. The aim of this study was to assess short-term patient outcomes and surgical results of SuperPATH hip replacements in Australia. Methods: A retrospective cohort analysis of the first 100 SuperPATH hip replacements by a single surgeon was performed. Surgical outcomes were reviewed with a minimum follow-up of 1 year post operation. A functional and patient satisfaction questionnaire was administered at a minimum of 6 weeks post operation. Results: There were 3 major complications with 1 revision operation in this series. There were no dislocations. By 2 weeks post operation, 86% of patients were ambulant without walking aids, 84% of patients were able to dress themselves independently and 91% of patients did not need opioid analgesia. 81% of patients were driving within 4 weeks of surgery. Of patients who were working full-time prior to surgery, 33% of them were back at work or functional baseline within 1 week post surgery, and 52% by 2 weeks. 100% of patients were extremely satisfied with the operation. Conclusion: We conclude that SuperPATH is a safe technique of hip arthroplasty with excellent functional recovery and patient satisfaction.